Filtered By:
Condition: Stroke
Management: Funding
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 633 results found since Jan 2013.
Many take anticoagulants and OTC supplements, which poses risk
FINDINGSNearly 98% percent of people prescribed direct-acting oral anticoagulants such as apixaban also used over-the-counter products. Of those, 33% took at least one such product that, in combination with the anticoagulants, could cause dangerous internal bleeding. People taking these medications largely lacked knowledge of some potentially serious interactions.BACKGROUNDDirect-acting oral anticoagulants are the drug of choice for stroke prevention in patients with atrial fibrillation, which occurs most frequently in older patients. Apixaban is one of the most frequently prescribed. However, most people prescribed apix...
Source: UCLA Newsroom: Health Sciences - October 31, 2019 Category: Universities & Medical Training Source Type: news
Quantitative Systems Pharmacology (QSP) for Neuroscience Drug Discovery and Development: Current Status, Opportunities and Challenges
The objective of the workshop was to identify the challenges and opportunities of QSP as an approach to accelerate drug discovery and development in the field of CNS disorders. In particular, the workshop examined the potential for computational neuroscience to perform QSP ‐based interrogation of the mechanism of action for CNS diseases, along with a more accurate and comprehensive method for evaluating drug effects and optimizing the design of clinical trials.Following up on an earlier white paper on the use of QSP in general disease mechanism of action and drug discovery, this report focuses on new applications, opport...
Source: CPT: Pharmacometrics and Systems Pharmacology - October 31, 2019 Category: Drugs & Pharmacology Authors: Hugo Geerts,
John Wikswo,
Piet H. van der Graaf,
Jane P.F Bai,
Chris Gaiteri,
David Bennett,
Susanne E Swalley,
Edgar Schuck,
Rima Kaddurah ‐Daouk,
Katya Tsaioun,
Mary Pelleymounter Tags: WHITE PAPER Source Type: research
Postcode lottery for NHS orthotics patients
Specialist orthotics care for patients with mobility issues varies significantly depending on where they live, research shows Related items fromOnMedica New funding for sports prosthetics for disabled children Lords demand an end to ‘national scandal’ on social care funding Rate of cognitive decline increases for years after stroke Men ’s dementia risk higher after androgen deprivation therapy Health professionals vary hugely in disability assessments
Source: OnMedica Latest News - October 27, 2019 Category: UK Health Source Type: news
2019 Cochrane-REWARD Prize winners announced
We are pleased to announce the winners – one first place and two runners-up – of this year’s Cochrane-REWARD Prize. The Cochrane-REWARD Prize recognizes successful local or pilot initiatives that have potential to reduce research waste globally if scaled up. Cochrane has funded the prize annually since it began in 2017.The prize ceremony took place on Wednesday 9 October at the International Clinical Trials Methodology Conference in Brighton, UK. Dr Joan Marsh, Deputy Editor of The Lancet Psychiatry and member of the prize committee, was there to hand out the prizes. During the conference, each recipient also had the...
Source: Cochrane News and Events - October 18, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news
Reducing Health Care Disparities in Sickle Cell Disease: A Review.
Authors: Lee L, Smith-Whitley K, Banks S, Puckrein G
Abstract
Sickle cell disease (SCD) is an inherited blood disorder most common among African American and Hispanic American persons. The disease can cause substantial, long-term, and costly health problems, including infections, stroke, and kidney failure, many of which can reduce life expectancy. Disparities in receiving health care among African Americans and other racial/ethnic minority groups in the United States are well known and directly related to poor outcomes associated with SCD. As an orphan disease-one that affects <200 000 persons nationwide-SCD ...
Source: Public Health Reports - October 11, 2019 Category: International Medicine & Public Health Tags: Public Health Rep Source Type: research
Forest Devices Is Crushing It This Year
Forest Devices added another feather to its cap at The MedTech Conference in Boston, MA where the startup won the MedTech Innovator 2019 Showcase and received a $350,000 grand prize award.
Forest is developing AlphaStroke, the first device designed to detect a stroke in any environment. The portable device uses electroencephalogram monitoring and machine learning to diagnose large vessel occlusions and other stroke subtypes, enabling first responders to triage patients to proper stroke centers. In 2018, the Pittsburgh, PA-based company closed an oversubscribed see...
Source: MDDI - October 7, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Aidoc releases full AI software package for stroke care
Israeli artificial intelligence (AI) software developer Aidoc has released...Read more on AuntMinnie.comRelated Reading:
Aidoc nabs NY contract for AI software
FDA clears Aidoc's AI for cervical spine fractures
Aidoc scores FDA clearance for pulmonary embolism AI
Aidoc raises $27M in funding round
Aidoc partners with Nuance on AI validation process
Source: AuntMinnie.com Headlines - September 19, 2019 Category: Radiology Source Type: news
Study shows how serotonin and a popular anti-depressant affect the gut ’s microbiota
In this study, we were interested in finding out why they might do so,” said Hsiao, UCLA assistant professor of integrative biology and physiology, and of microbiology, immunology and molecular genetics in the UCLA College; and of digestive diseases in the David Geffen School of Medicine at UCLA.Hsiao and her research group reported in the journal Cell in 2015 that in mice, a specific mixture of bacteria, consisting mainly of Turicibacter sanguinis and Clostridia, produces molecules that signal to gut cells to increase production of serotonin. When Hsiao’s team raised mice without the bacteria, more than 50% of t...
Source: UCLA Newsroom: Health Sciences - September 6, 2019 Category: Universities & Medical Training Source Type: news
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
We describe the prevalence, hazard ratios (HRs), and population-attributable fractions (PAFs) for cardiovascular disease and mortality associated with a cluster of behavioural factors (ie, tobacco use, alcohol, diet, physical activity, and sodium intake), metabolic factors (ie, lipids, blood pressure, diabetes, obesity), socioeconomic and psychosocial factors (ie, education, symptoms of depression), grip strength, and household and ambient pollution. Associations between risk factors and the outcomes were established using multivariable Cox frailty models and using PAFs for the entire cohort, and also by countries grouped ...
Source: The Lancet - September 3, 2019 Category: General Medicine Source Type: research
Association between depression risk and polycystic ovarian syndrome in young women: a retrospective nationwide population-based cohort study (1998 –2013)
This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW108-TDU-B-212-133 004), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039 -004-), Tseng-Lien Lin Foundation, Taichung, Taiwan and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. No competing interest existe d.TRIAL REGISTRATION NUMBERN/A.
Source: Human Reproduction - August 13, 2019 Category: Reproduction Medicine Source Type: research
Achieving GP diabetes targets could boost health and cut costs
Possible 30 years life gain per 100 patients and £727m savings Related items fromOnMedica CCGs must focus more on foot care Shocking variation in diabetes care across UK Coronary heart disease remains UK ’s biggest killer The new GP contract: transforming primary care, transforming CVD prevention Dementia and stroke funding remains too low, say experts
Source: OnMedica Latest News - August 11, 2019 Category: UK Health Source Type: news
Athens biotech firm treating ALS, strokes raises $13M
ArunA Bio, a biotech company based in Athens, has raised $13 million from Eshelman Ventures, members of the company ’s board of directors and management, and other investors.
ArunA Bio will use the funding to support the development of its neural exosome delivery platform and neural exosome therapies for treating neurodegenerative diseases such as ALS, Huntington’s Disease and stroke, according to a news re lease. Company representatives said the new funding brings ArunA Bio’s total raised…
Source: bizjournals.com Health Care:Biotechnology headlines - July 29, 2019 Category: Biotechnology Authors: Madison Hogan Source Type: news
Medtronic, Viz.ai team up on stroke care
Device manufacturer Medtronic has partnered with artificial intelligence (AI)...Read more on AuntMinnie.comRelated Reading:
Philips inks Medtronic collaboration
Medtronic recalls StealthStation brain imaging software
Mazor Robotics shareholders approve Medtronic deal
Viz.ai adds $21M in new funding
FDA OK's Viz.ai's CT software
Source: AuntMinnie.com Headlines - July 22, 2019 Category: Radiology Source Type: news
DFG to fund ten new research units, two clinical research units and one centre for advanced studies
(Deutsche Forschungsgemeinschaft) Topics range from stroke recovery and anti-allergy measures to new measurement techniques for communication / Approximately 47 million for first funding period.
Source: EurekAlert! - Medicine and Health - July 12, 2019 Category: International Medicine & Public Health Source Type: news
